Navigation Links
The Law Firm of d'Oliveira & Associates Now Offers a No Win - No Fee Promise in Fosamax Cases
Date:12/28/2012

(PRWEB) December 28, 2012

Law Firm Offers No Win - No Fee Promise For Clients injured from the drug Fosamax, used to treat bone-weakening diseases. Fosamax has allegedly been linked to serious side effects, such as femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain.

Attribution: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm229171.htm

The personal injury lawyers at d'Oliveira & Associates are working with some of the leading lawyers in the country and are seeking currently clients who have suffered from femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain while using Fosamax. They are offering a “no win - no fee promise” to those who took Fosamax, which means that there is no legal fees due until the case is settled or an award is received.

Recent news shows promise that the lawsuits are moving forward for the plaintiffs who have filed lawsuits against Fosamax. New Jersey Superior Court has scheduled the next status conference on the consolidated Fosamax litigation for December 18, 2012 at 10:00am. (In re: Fosamax Litigation, No. 282, N.J. Super. Ct). Additionally, femur fracture lawsuits against Fosamax are pending in a multidistrict litigation (MDL) in the U.S. District Court in the District of New Jersey. (In re: Fosamax (Alendronate Sodium) Products Liability Litigation (No. II) - MDL No. 2243). According to state records, the first trials against Fosamax in both state and federal courts are expected to begin next spring.

A study published in October 2012 by the Journal of Clinical Endocrinology & Metabolism indicates that patients suffering from atypical femur fractures also experienced delayed healing, prodromal pain (pain experienced prior to the actual fracture), and persisting risk of a contralateral and/or other fracture. In this study, the author analyzed 81 patients who had suffered atypical femur fractures while taking biphosphonates, the generic name for Fosamax, for treatment of osteoporosis for an average of 9.5 years, and 94% of these patients have been taken Fosamax. Another study of more than 300 cases conducted by the American Society of Bone and Mineral Research Subtrochanteric Femoral Fracture Task Force found that most of those that suffered fractures had been on the drug for five years or more. They also found that more than half of the patients studied had experience groin or thigh pain for a period of weeks or months before their fractures occurred.

As a result of these studies, the U.S. Food and Drug Administration issued a warning about Fosamax. The FDA mandated that the drug manufacturer include information in its Warnings and Precautions section of the drug labels about the possible associations between the atypical thigh fractures and the Fosamax. FDA mentioned that although these types of fractures account for only 1% of all hip and femur fractures overall, they have been predominantly reported by patients who have been taking Fosamax for at least 5 years.

Attorney Paul d’Oliveira stated that “our office is doing all we can to let the public know that if they have been injured by Fosamax that they can be compensated for their injuries at no cost to them until their case settles or until they receive a monetary reward.”

To help protect the rights of individuals who may have suffered injuries such as femur fractures, osteonecrosis of the jaw injury, esophageal cancer, and severe musculoskeletal pain while using Fosamax, d'Oliveira & Associates is offering a No Win - No Fee Promise. Those who choose to hire d'Oliveira & Associates will be charged no fee unless they recover monetary damages, such as through a settlement or judgment.

d’Oliveira and Associates is a law firm that is working with some of the leading attorneys in the United States for dangerous drug, defective medical products and medical malpractice cases. The firm also focuses on personal injury cases, including auto accidents, slip and falls, dog bites, as well as social security disability cases.

For a free consultation, call 1-800-992-6878 or visit their website at Fosamax Lawyer

Read the full story at http://www.prweb.com/releases/2012/12/prweb10270800.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d'Oliveira & Associates Helps Newport Woman Receive $150,000 Settlement for Auto Accident; Case: MI-11889
2. d'Oliveira & Associates Helps Rhode Island Estate Receive the Maximum Compensation Under RI Law of $250,000 Settlement for Fatal Auto Accident
3. d'Oliveira & Associates Helps Westport, MA Man Receive $100,000 Settlement for Reckless Driving Accident
4. d'Oliveira & Associates Help New Bedford Woman Receive $95,000 in Damages for Dog Bite Injury Case #:NB-11736
5. Carey Danis & Lowe Issues an Update on the Pradaxa Multi-District Litigation No. 2385
6. A Serious Problem: Medical Malpractice Lawyers at Console & Hollawell React to Alarming Doctor Error Statistics from Johns Hopkins University Researchers
7. Hillsborough Audiology & Hearing Aid Center, Inc — Provider of Hearing Aids in Sun City Center, FL — Reannounces New Offer for Complimentary Hearing Screening and Consultation
8. ABC Home & Commercial Services’ Houston Branch Now Offering Discount on Initial Service with Signature Rodent Agreement
9. Tips for Making the Holidays Safer and Calmer for Dementia Patients from Pathways Home Health & Hospice
10. New Jersey Accident Lawyers at Console & Hollawell Commend Montgomery County’s ‘Operation Safe Holiday,’ Urge All to Participate
11. Zane Benefits Posts Information & Videos on Defined Contribution Healthcare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2017)... ... August 20, 2017 , ... Are you an adult with ... If so, you may be interested in participating in a research study that focuses ... is to understand more about the relational aspects of adults who have gluten sensitivities ...
(Date:8/19/2017)... Rockville, MD (PRWEB) , ... August 18, 2017 ... ... Food and Drug Administration Reauthorization Act of 2017, legislation that provides for greater ... perceived mild to moderate hearing loss to access OTC hearing aids without being ...
(Date:8/19/2017)... ... August 19, 2017 , ... Yesterday, the President of the ... there are two sides. There are not two sides to hatred, bigotry, discrimination, and ... and prejudice, and the NPEIV stands against all forms of such hatred and discrimination ...
(Date:8/18/2017)... ... August 19, 2017 , ... Mr. Noppadon Pakprot, Deputy Governor ... Thailand Health and Wellness Tourism Showcase 2017 yesterday, which unveiled the latest “Functional ... Tourism Products and Business at TAT said, “Thailand has long been recognized as ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet ... advocating for active, healthy lifestyles and highlighting the importance of proactive eye and ... impairments and shares the latest innovations in hearing aid technology. , In ...
Breaking Medicine News(10 mins):
(Date:8/8/2017)... Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), ... today reports its financial results for the second quarter ... during the second quarter 2017 and to date: ... clinical development programs for the Company,s lead project, BL-8040: ... pivotal study with BL-8040 as novel stem cell mobilization ...
(Date:8/7/2017)... , Aug. 7, 2017 Diplomat Pharmacy, Inc. (NYSE: ... Joel Saban as president, effective Aug. 7, 2017. ... has decided to pursue other interests and will serve as ... tenure, Paul has served us in multiple leadership roles since ... in Jun. 2015 and has provided decisive, strategic leadership which ...
(Date:8/4/2017)... Aug. 3, 2017  Agragen, LLC, a ... in the biopharmaceutical, nutraceutical, and aquacultural feed sectors, ... its lead drug candidates, AGR131.  This drug is ... from the blood of patients suffering from inflammatory ... bowel disease. ...
Breaking Medicine Technology: